GILEAD SCIENCES, INC. - Common Stock (GILD)

Q4 2024 13F Holders as of 31 Dec 2024

Type / Class
Equity / Common Stock
Shares outstanding
1,240,722,841
Total 13F shares
1,061,928,121
Share change
+16,830,352
Total reported value
$98,045,307,663
Put/Call ratio
109%
Price per share
$92.37
Number of holders
1,868
Value change
+$1,597,585,192
Number of buys
796
Number of sells
811

Institutional Holders of GILEAD SCIENCES, INC. - Common Stock (GILD) as of Q4 2024

As of 31 Dec 2024, GILEAD SCIENCES, INC. - Common Stock (GILD) was held by 1,868 institutional shareholders that filed Form 13F with the SEC. Together, they reported ownership of 1,061,928,121 shares. The largest 10 holders included BlackRock, Inc., VANGUARD GROUP INC, Capital World Investors, STATE STREET CORP, Capital Research Global Investors, FMR LLC, WELLINGTON MANAGEMENT GROUP LLP, Dodge & Cox, GEODE CAPITAL MANAGEMENT, LLC, and MORGAN STANLEY. This page lists 1,872 institutional shareholders reporting positions in this security for the Q4 2024 filing period.
Investor Option Weight % Change % Value $ * Price Shares Share Change Activity Report Period
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.